Join BSAC | Members area

Search the BSAC site

Antimicrobial Chemotherapy Conference 2019

In collaboration with Global Antibiotic Research & Development Partnership (GARDP)

Presentation Details	Videos
Opening remarks Professor Laura Piddock, Head of Scientific Affairs, Global Antibiotic R&D Partnership (GARDP)	Watch Presentation Download Presentation
The risks of clinical development from the perspective of the antibacterial discovery scientist Dr David Shlaes, Former Professor of Medicine, Case Western Reserve University, Ohio, USA	Watch Presentation Download Presentation
Overview of new antibiotics in development Professor David Livermore, Professor of Medical Microbiology, University of East Anglia	Watch Presentation Download Presentation
Overview of new antifungals in development Professor David Denning, Professor of Infectious Diseases in Global Health, University of Manchester	Watch Presentation Download Presentation
Things clinicians don’t often consider (CMC, GLP toxicology, Phase I studies) Dr Lauren Walker, Clinical Lecturer at Royal Liverpool University Hospital	Watch Presentation Download Presentation
PK-PD programs for drug development Professor George Drusano, University of Florida and an Institute Director (Institute for Therapeutic Innovation)	Watch Presentation Download Presentation
Invited paper – Identifying carbapenem and amikacin-sparing first-line combination therapy for neonatal sepsis in high extended-spectrum beta-lactamase (ESBL) prevalence settings Dr Joe Standing, Principal Research Associate (MRC fellow), UCL Great Ormond Street Institute of Child Health	Watch Presentation Download Presentation
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of beta-lactamase inhibiter combinations Dr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology, University of Liverpool	Watch Presentation Download Presentation
Metallobetalactamases and development of new compounds Dr Martin Everett, Chief Scientific Officer, Antabio	Watch Presentation Download Presentation
Invited paper – REVIVE – a programme to support and connect the antimicrobial R&D community Astrid Pentz-Murr, Community manager REVIVE, GARDP	Watch Presentation Download Presentation
Stimulating Antibiotic R&D through links to sustainable use and novel economic incentives Dr Ursula Theuretzbacher, Founder, Center for Anti-Infective Agents	Watch Presentation Download Presentation
Developing a new drug for STIs Dr Emilie Alirol, Project Leader, Sexually Transmitted Infections, Global Antibiotic R&D Partnership (GARDP)	Watch Presentation Download Presentation
Clinical Trial Design for new antimicrobials: adults Mr Aaron Dane, Director, DaneStat Consulting Limited	Watch Presentation Download Presentation

Event details

15 January 2019

Seligman Theatre, Royal College of Physicians, London

Join us

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.

Become a member

Sign up for Transmission:
Our monthly newsletter, packed full of opportunities, events, guidance and updates

Having trouble finding what you're after?

Who we are

Get in touch

Information

53 Regent Place, Birmingham B1 3NJ

Registered Charity

Search the BSAC site

Antimicrobial Chemotherapy Conference 2019

Opening remarks

The risks of clinical development from the perspective of the antibacterial discovery scientist

Overview of new antibiotics in development

Overview of new antifungals in development

Things clinicians don’t often consider (CMC, GLP toxicology, Phase I studies)

PK-PD programs for drug development

Invited paper – Identifying carbapenem and amikacin-sparing first-line combination therapy for neonatal sepsis in high extended-spectrum beta-lactamase (ESBL) prevalence settings

Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of beta-lactamase inhibiter combinations

Metallobetalactamases and development of new compounds

Invited paper – REVIVE – a programme to support and connect the antimicrobial R&D community

Stimulating Antibiotic R&D through links to sustainable use and novel economic incentives

Developing a new drug for STIs

Clinical Trial Design for new antimicrobials: adults